For the Inventor, By the Inventor

Enter assignee name

Uttar Pradesh, India

Jubilant Generics Limited

USPTO Granted Patents = 19

% Expired Patents = 52.6

CIPO Patents = 9

EPO Patents = 6

Forward Citations = 13

Loading Chart...

Loading Chart...

62 inventors (with patents filed for the assignee):

Dinesh Kumar (10 out of 12 patents)

Kamal Surendrakumar Mehta (9 out of 12 patents)

Ganesh Vinayak Gat (7 out of 10 patents)

4. Saurabh Srivastava (6 out of 6 patents)

5. Indranil Nandi (6 out of 18 patents)

6. Dharam Vir (5 out of 8 patents)

7. Amit Jha (4 out of 4 patents)

8. Rakesh K Singh (3 out of 3 patents)

9. Rajendra Shekhawat (3 out of 3 patents)

10. Ravikumar Nithiyanandam (3 out of 3 patents)

11. Sujay Biswas (3 out of 5 patents)

12. Premchand Dalichandji Nakhat (2 out of 7 patents)

13. Subash Chandra Mohanta (2 out of 2 patents)

14. Sunil Kumar Panda (2 out of 2 patents)

15. Pankaj Soni (2 out of 2 patents)

19 patents: Sort by Forward Citations

1. 11642351 - Eslicarbazepine suspension (2023-05-09),

2. 11471543 - Pharmaceutical compositions of sulfur colloid and processes thereof (2022-10-18),

3. 11331324 - Modified release suspension of eslicarbazepine (2022-05-17),

4. 11327065 - Preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof (2022-05-10),

5. 11318145 - Eslicarbazepine suspension (2022-05-03),

6. 11020349 - Transmucosal dosage forms of remdesivir (2021-06-01),

7. 10946002 - Pharmaceutical suspension dosage form of benzimidazole compounds and process of preparation thereof (2021-03-16),

8. 10918630 - Delayed release pharmaceutical composition of pantoprazole and process for formulation thereof (2021-02-16),

9. 10918604 - Solid oral dosage forms of eslicarbazepine (2021-02-16),

10. 10889549 - Continuous process for the preparation of 2-(1H-imidazol-4-yl) ethanamine and pharmaceutically acceptable salts thereof (2021-01-12),

11. 10888519 - Immediate release pharmaceutical composition of iron chelating agents (2021-01-12),

12. 10836781 - Process for the preparation of tetrofosmin or acid salt thereof (2020-11-17),

13. 10813916 - Immediate release pharmaceutical composition of tizanidine (2020-10-27),

14. 10537562 - Delayed release pharmaceutical composition of pantoprazole and process for formulation thereof (2020-01-21),

15. 10426770 - Process for the preparation of Lurasidone hydrochloride (2019-10-01),

Jubilant Generics Limited, based in Uttar Pradesh, India, specializes in the development and manufacturing of generic pharmaceuticals. The company focuses on a diverse range of therapeutic areas, including oncology, cardiology, and anti-infectives, leveraging advanced technologies to enhance drug formulation and delivery. With a commitment to quality and innovation, Jubilant Generics aims to provide affordable healthcare solutions globally, contributing to the accessibility of essential medicines across various markets.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

19 Patents

#3 in

#102 in

#32,620 in the World

Uttar Pradesh, India

Jubilant Generics Limited

Forward Citations = 13

62 inventors:

Dinesh Kumar (10 out of 12 patents)

Kamal Surendrakumar Mehta (9 out of 12 patents)

Ganesh Vinayak Gat (7 out of 10 patents)

4. Saurabh Srivastava (6 out of 6 patents)

5. Indranil Nandi (6 out of 18 patents)

Please report any incorrect information to [email protected]

Loading…